These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22424333)

  • 1. The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer.
    Kolkova Z; Casslén V; Henic E; Ahmadi S; Ehinger A; Jirström K; Casslén B
    J Ovarian Res; 2012 Mar; 5():9. PubMed ID: 22424333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer.
    Jala VR; Radde BN; Haribabu B; Klinge CM
    BMC Cancer; 2012 Dec; 12():624. PubMed ID: 23273253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua.
    Kolkova Z; Noskova V; Ehinger A; Hansson S; Casslén B
    Mol Hum Reprod; 2010 Oct; 16(10):743-51. PubMed ID: 20508064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPER-1 acts as a tumor suppressor in ovarian cancer.
    Ignatov T; Modl S; Thulig M; Weißenborn C; Treeck O; Ortmann O; Zenclussen A; Costa SD; Kalinski T; Ignatov A
    J Ovarian Res; 2013 Jul; 6(1):51. PubMed ID: 23849542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Estrogen Receptors in Relation to Hormone Levels and the Nottingham Prognostic Index.
    Fahlén M; Zhang H; Löfgren L; Masironi B; VON Schoultz E; VON Schoultz BO; Sahlin L
    Anticancer Res; 2016 Jun; 36(6):2839-47. PubMed ID: 27272795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer.
    Friese K; Kost B; Vattai A; Marmé F; Kuhn C; Mahner S; Dannecker C; Jeschke U; Heublein S
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):13-19. PubMed ID: 28924735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers.
    Hernández-Silva CD; Villegas-Pineda JC; Pereira-Suárez AL
    Front Endocrinol (Lausanne); 2020; 11():544. PubMed ID: 32973677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
    Yan Y; Jiang X; Zhao Y; Wen H; Liu G
    Cell Biochem Funct; 2015 Dec; 33(8):552-9. PubMed ID: 26526233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the G protein-coupled estrogen receptor (GPER) in human prostate: expression site of the estrogen receptor in the benign and neoplastic gland.
    Rago V; Romeo F; Giordano F; Ferraro A; Carpino A
    Andrology; 2016 Jan; 4(1):121-7. PubMed ID: 26714890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmembrane estrogen receptor GPR30 is more frequently expressed in malignant than benign ovarian endometriotic cysts and correlates with MMP-9 expression.
    Long L; Cao Y; Tang LD
    Int J Gynecol Cancer; 2012 May; 22(4):539-45. PubMed ID: 22495744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The G-protein-coupled estrogen receptor (GPER/GPR30) in ovarian granulosa cell tumors.
    Heublein S; Mayr D; Friese K; Jarrin-Franco MC; Lenhard M; Mayerhofer A; Jeschke U
    Int J Mol Sci; 2014 Aug; 15(9):15161-72. PubMed ID: 25167139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells.
    Liu H; Yan Y; Wen H; Jiang X; Cao X; Zhang G; Liu G
    Cell Biol Int; 2014 May; 38(5):631-8. PubMed ID: 24446390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
    Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
    Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y; Birnbaumer L; Teng CT
    Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer.
    Sjöström M; Hartman L; Grabau D; Fornander T; Malmström P; Nordenskjöld B; Sgroi DC; Skoog L; Stål O; Leeb-Lundberg LM; Fernö M
    Breast Cancer Res Treat; 2014 May; 145(1):61-71. PubMed ID: 24715381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
    Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
    Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER.
    Girgert R; Emons G; Gründker C
    Front Endocrinol (Lausanne); 2018; 9():781. PubMed ID: 30687231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
    Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
    Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
    Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation.
    Molina L; Bustamante F; Ortloff A; Ramos I; Ehrenfeld P; Figueroa CD
    Front Endocrinol (Lausanne); 2020; 11():563165. PubMed ID: 33117280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.